Secretory products of breast cancer cells specifically affect human osteoblastic cells: Partial characterization of active factors

Journal of Bone and Mineral Research

Volumn 12, Issue 4, 1997, Pages 552-560

  Siwek, Brigitte ^a   Lacroix, Marc ^a   De Pollak, Cindy ^b   Marie, Pierre ^b   Body, Jean Jacques ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PARATHYROID HORMONE;

ARTICLE; BONE DESTRUCTION; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; OSTEOBLAST; OSTEOLYSIS;

EID: 0030992189     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.4.552     Document Type: Article

References (29)

1. Body JJ 1992 Metastatic bone disease: Clinical and therapeutic aspects. Bone 13:57-62.
2. Coleman RE, Rubens RD 1987 The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66.
3. Eilon G, Mundy GR 1978 Direct resorption of bone by human breast cancer cells in vitro. Nature 276:726-728.
4. Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA 1994 Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 15:161-166.
5. Mundy GR 1991 Mechanisms of osteolytic bone destruction. Bone 12:S1-S6.
6. Athanasou NA, Quinn JM 1992 Human tumour-associated macrophages are capable of bone resorption. Br J Cancer 65:523-526.
7. McSheehy PMJ, Chambers TJ 1986 Osteoblast-like cells in the presence of parathyroid hormone release a soluble factor that stimulates osteoclastic bone resorption. Endocrinology 119:1654-1659.
8. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 80:425-429.
9. Datta HK, Zaidi M, Champaneri JB, MacIntyre I. 1989 Transforming growth factor-beta-induced mitogenesis of human bone cancer cells. Biochem Biophys Res Commun 161:672-676.
10. Seitz PK, Zhu BT, Cooper CW 1992 Effect of transforming growth factor beta on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells. J Bone Miner Res 7:541-546.
11. Lacroix M, Siwek B, Body JJ 1996 Effects of secretory products of breast cancer cells on osteoblast-like cells. Br Cancer Res Treat 38:209-216.
12. Polanowski FP, Gaffney EV, Burke RE 1976 HBL-100, a new cell line established from human breast milk. In Vitro 12:328-338.
13. Marie PJ, Lomri A, Sabbagh A, Basle M 1989 Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Dev Biol 25:373-380.
14. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J Immunol Meth 65:55-63.
15. Heath H III, Purnell DC 1980 Urinary cyclic 3′,5′-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism. J Lab Clin Med 96:974-984.
16. Body JJ, Borkowski A, Cleeren A, Bijvoet OLM 1986 Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate. J Clin Oncol 4:1177-1183.
17. Dodwell DJ 1992 Malignant bone resorption: Cellular and biochemical mechanisms. Ann Oncol 3:257-267.
18. Stewart AF, Vignery A, Silvergate A, Ravin ND, LiVolsi V, Broadus AE, Baron R 1982 Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: Uncoupling of bone cell activity. J Clin Endocrinol Metab 55:219-227.
19. Guise TA, Yoneda T, Yates AJ, Mundy GR 1993 The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-a enhance hypercalcemia in vivo and bone resorption in vitro. J Clin Endocrinol Metab 77:40-45.
20. Guise TA, Mundy GR 1995 Breast cancer and bone. Curr Opin Endocrinol Diabetes 2:548-555.
21. 2 in normal and posmenopausal osteoporotic women. J Bone Miner Res 5:1149-1155.
22. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ 1991 Localization of parathyroid hormone-related protein in breast cancer metastasis: Increased incidence in bone compared with other sites. Cancer Res 51:3059-3061.
23. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul M, Jullienne A 1993 Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 53:5076-5078.
24. Nijs-De Wolf N, Pepersack T, Corvilain J, Karmali R, Bergmann P 1991 Adenylate cyclase stimulating activity immunologically similar to parathyroid hormone-related peptide can be extracted from fetal rat long bones. J Bone Miner Res 6:921-927.
25. Yates AJ, Favarato G, Aufdemorte TB, et al 1992 Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increases osteoclastic bone resorption. J Bone Miner Res 7:847-853.
26. Bebok Z, Markus B, Nemeth P 1994 Pronostic relevance of transforming growth factor alpha (TGF-α) and tumor necrosis factor alpha (TNF-α) detected in breast cancer tissues by immunohistochemistry. Br Cancer Res Treat 29:229-235.
27. Thomson BM, Mundy GR, Chambers TJ 1987 Tumor necrosis factor alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779.
28. Clohisy DR, Palkert D, Ramnaraine MLR, Pekurovsky I, Oursler MJ 1996 Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J Orthop Res 14:396-402.
29. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ 1993 Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91:2004-2011.